NEW BRUNSWICK, N.J., Dec. 17, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that the Board of Directors has authorized the repurchase of up to $5 billion of the company's common stock. "Based on our continued strong performance and, more importantly, the confidence we have in our business going forward, the Board of Directors and management team believe that
SCHLIEREN (ZURICH), Switzerland, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX: KURN) has completed a transformational year, having realized first sales of its MagnetOs bone graft substitute in the U.S. and Europe and raised capital to support the roll-out of MagnetOs, and fund the Phase II clinical trial of fibrin-PTH (KUR-113) in spinal fusion.
BILLERICA, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique anatomy, today announced it is implementing steps to improve its overall business model, including the prioritization of certain
WARSAW, Ind., Dec. 14, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. has been granted a global, non-exclusive license for the sale of a patented guided growth plating system in children with deformed limbs. These 3 patents were created and designed for the gradual correction of pediatric deformities in both the upper and lower extremities. WishBone
Dublin, Dec. 13, 2018 (GLOBE NEWSWIRE) -- The "Sports Medicine Devices Market to 2025 - Global Analysis and Forecasts By Product, Application, and Geography" report has been added to ResearchAndMarkets.com's offering. The global sports medicine devices market is expected to reach US$ 10,662.5 Mn in 2025 from US$ 5,822.6 Mn in 2017. The market is estimated to grow with
WARSAW, Ind., Dec. 13, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the full-scale U.S. launch of its 26th surgical system, the RESPONSE 4.5/5.0mm System following U.S. Food and Drug Administration (FDA) 510(k) clearance in October. The Company’s newest system represents a significant product expansion
OVERLAND PARK, Kan., Dec 13, 2018 /PRNewswire/ -- Overland Park Surgical Suites is a state of the art outpatient surgical center and is the first outpatient surgery center in the Midwest to offer patients a robotics-assisted alternative to traditional knee replacement surgery. "We were eager to bring the NAVIO robotics-assisted surgery to the area," said Scott Abraham, M.D.,
WARSAW, Ind., Dec. 12, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2018. The cash dividend of $0.24 per share is payable on January 31, 2019 to stockholders of record as
December 12, 2018 CHICAGO--(BUSINESS WIRE)--EDGe Surgical, Inc., a privately held medical device company dedicated to innovative precision measurement solutions for orthopedic surgery, announced today that it has completed $4 million in financing. The Series A round includes $3 million raised plus a convertible note, bringing total funding secured by the company to $5.7 million, all
Reston, Virginia, Dec. 12, 2018 (GLOBE NEWSWIRE) -- The Virginia Institute of Robotic Surgery at Reston Hospital Center has acquired a second Mazor X System for their rapidly growing spine program, making it the first in the nation to have two of these robotic systems at one hospital location. The Reston Hospital Center (RHC) Spine Team is
